• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Kurve Technology wins DoD contract for drug delivery tech

May 31, 2019 By Danielle Kirsh

kurve-technologyKurve Technology won a U.S. Defense Dept. contract to test a new formulation for combating traumatic brain injuries.

The Mill Creek, Wash.-based company makes a controlled particle dispersion device designed to deliver liquid drugs through a controlled, turbulent flow, according to the company’s website. Its ViaNase electronic atomizer can deliver most drug compounds through the nose and has thousands of device configurations. Kurve Technology first received a patent for the nasal drug delivery technology in 2007.

“We are pleased that the DoD recognizes the value we bring to intranasally-challenging drug delivery. This is our third collaboration with the DoD and we look forward to taking it to fruition. We are currently involved in 17 nose-to-brain clinical studies, and with this one, we expect to be dosing by mid-summer,” CEO Marc Giroux said in a press release.

Kurve is participating in two other DoD projects for post-traumatic stress disorder in New York City. One project has completed Phase I trials and is moving into Phase II, the company said.

“We are grateful that the DoD takes on studies that affect large numbers of civilians, not just servicemen. Their efforts will benefit the sufferers along with their families whose lives are also severely impacted by these conditions,” Giroux said.

Kurve Technology devices are designed to bypass the blood-brain barrier to improve the quality of life of people who have neurodegenerative diseases and neurological disorders. The devices are also used for topical and systemic therapies that are typically done in nasal drug delivery.

Filed Under: Drug-Device Combinations, Neurological Tagged With: Kurve Technology

IN CASE YOU MISSED IT

  • Dexcom updates CGM receiver recall that led to serious adverse events
  • Abbott reports momentum with Libre CGM business as new dual sensor will ‘accelerate’ growth
  • Johnson & Johnson wins FDA priority review for drug delivery system
  • Glucose monitoring company LifeScan files chapter 11 to reduce debt
  • Medtronic enrolls first patient in study for Onyx liquid embolic system

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS